The CEO of UVD Robots explains why robots can be effective in fighting the coronavirus and how his company is scaling up to meet demand.
Wuhan Coronavirus Pandemic — USA
California has the first case that cannot be traced back to a traveler from an area with an outbreak.
“It’s significant because it means that it’s also possible the infection is spreading untraced throughout the local community.”
“U.S. health officials confirmed the first possible community transmission of the coronavirus in America, a troubling sign that the virus could be spreading in local cities and towns. The Centers for Disease Control and Prevention doesn’t know exactly how the California patient contracted the virus. The individual is a resident of Solano County and is receiving medical care in Sacramento County. The patient didn’t have a relevant travel history or exposure to another patient with the virus, the CDC said.”
The CDC doesn’t know exactly how the patient, a California resident, contracted the virus.
Photoacoustic imaging, a technique for examining living materials through the use of laser light and ultrasonic sound waves, has many potential applications in medicine because of its ability to show everything from organs to blood vessels to tumors.
Caltech’s Lihong Wang, a pioneer in the field, has developed variants of photoacoustic imaging that can show organs moving in real time, develop three-dimensional (3D) images of internal body parts, and even differentiate cancerous cells from healthy cells.
Wang, Bren Professor of Medical Engineering and Electrical Engineering, has now further advanced photoacoustic imaging technology with what he calls Photoacoustic Topography Through an Ergodic Relay (PATER), which aims to simplify the equipment required for imaging of this type.
For now, it’s a simple network. But, it could be an important first step toward smarter and more adaptive prosthetics and brain-computer interfaces — and potentially lay the groundwork for a world where neural implants create real brain networks.
“On one side it sets the basis for a novel scenario that was never encountered during natural evolution, where biological and artificial neurons are linked together and communicate across global networks; laying the foundations for the Internet of Neuro-electronics,” Themis Prodromakis, a nanotechnology researcher and director at the University of Southampton’s Centre for Electronics Frontiers said in a press release.
“On the other hand, it brings new prospects to neuroprosthetic technologies, paving the way towards research into replacing dysfunctional parts of the brain with AI chips.”
Cardiologists at The Ohio State University Wexner Medical Center are the first in the United States to test a new type of ablation technology for patients suffering from atrial fibrillation, a common type of irregular heartbeat.
The team is participating in a global clinical trial to assess pulsed field ablation (PFA) technology to treat patients with atrial fibrillation. Developed by.
Ogba Educational Clinic
A nightmarish scene was burnt into my memory nearly two decades ago: Changainjie, Beijing’s normally chaotic “fifth avenue,” desolate without a sign of life. Schools shut, subways empty, people terrified to leave their homes. Every night the state TV channels reported new cases and new deaths. All the while, we had to face a chilling truth: the coronavirus, SARS, was so novel that no one understood how it spread or how to effectively treat it. No vaccines were in sight. In the end, it killed nearly 1,000 people.
It’s impossible not to draw parallels between SARS and the new coronavirus outbreak, COVID-19, that’s been ravaging China and spreading globally. Yet the response to the two epidemics also starkly highlights how far biotech and global collaborations have evolved in the past two decades. Advances in genetic sequencing technologies, synthetic biology, and open science are reshaping how we deal with potential global pandemics. In a way, the two epidemics hold up a mirror to science itself, reflecting both technological progress and a shift in ethos towards collaboration.
Let me be clear: any response to a new infectious disease is a murky mix of science, politics, racism, misinformation, and national egos. It’s naïve to point to better viral control and say it’s because of technology alone. Nevertheless, a comparison of the two outbreaks dramatically highlights how the scientific world has changed, for the better, in the last two decades.
They don’t waste much time getting right into it. He is 57 but has been told he is physically 47.
Dr. Aubrey de Grey of SENS Research Foundation was interviewed by the extremely popular Joe Rogan, and they discussed the damage repair approach to aging. Dr. de Grey talked about the current state of aging research, including stem cell therapies, and explained the role of SENS in developing next-generation rejuvenation biotechnology therapies. He also brought up the role of funding, a key bottleneck in research and development, and gave his prognosis on how quickly these therapies will be developed.